Glenmark Pharmaceuticals Limited



Glenmark Pharmaceuticals Limited has informed the Exchange regarding a press release dated September 23, 2026, titled “Glenmark Pharmaceuticals receives Establishment Inspection Report (EIR) from U.SFDA for its Goa facility with VAI classification”|SUBJECT: Press Release



Source link

Leave a Reply

Your email address will not be published. Required fields are marked *